Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122646) titled 'Clinical validation of artificial intelligence model based on DCE-MRI for predicting the efficacy of neoadjuvant chemotherapy combined with immunotherapy in locally advanced triple negative breast cancer: a multicenter, observational, prospective study' on April 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Observation group:85;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...